## ISRG: Intuitive Surgical, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -1.7% below STRENGTH zone (3.0-6.0%); PEG 2.79 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($541.83)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Marshall Wace LLP Has $79.30 Million Position in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251206T110804 | Somewhat-Bullish | Relevance: 99%
-  Marshall Wace LLP significantly increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 78% in Q2, bringing its stake to $79.30 million. Wall Street analysts maintain a largely bullish outlook on ISRG, with a "Moderate Buy" consensus and an average price target of $607.17. Despite insider selling totaling approximately $60.76 million recently, institutional investors collectively own 83.64% of the company's stock.

**2. Specialty Stocks Q3 Earnings: Intuitive Surgical (NASDAQ:ISRG) Best of the Bunch**
- Source: Finviz | 20251208T095557 | Bullish | Relevance: 99%
-  Intuitive Surgical led the specialty surgical equipment sector in Q3 earnings, surpassing analyst expectations with 22.9% year-on-year revenue growth. Other companies like Teleflex had mixed results, while Integra LifeSciences and LeMaitre showed weaker performance, missing estimates and experiencing stock declines. Overall, the sector's revenues and guidance aligned with consensus, with share prices up 1.4% on average.

**3. Federated Hermes Inc. Lowers Stake in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251207T121205 | Somewhat-Bullish | Relevance: 99%
-  Federated Hermes Inc. reduced its holding in Intuitive Surgical, Inc. by 3.0% in the second quarter, selling 9,678 shares and now owning 313,035 shares valued at $170.1 million. This comes as company insiders have actively sold shares, with a total of 108,939 shares worth approximately $60.76 million being sold over the last three months. Despite institutional selling, Wall Street analysts generally maintain a "Moderate Buy" rating for Intuitive Surgical, with an average price target of $607.17.

**4. Jump Financial LLC Purchases 8,815 Shares of Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251207T114325 | Bullish | Relevance: 99%
-  Jump Financial LLC increased its stake in Intuitive Surgical, Inc. by 16.8%, acquiring an additional 8,815 shares, bringing their total holdings to 61,379 shares valued at approximately $33.35 million. This move is part of a broader trend of increased institutional investment in ISRG, with major entities like Norges Bank and Vanguard Group significantly expanding their positions. Intuitive Surgical, Inc. recently exceeded quarterly earnings estimates and maintains a "Moderate Buy" consensus rating from Wall Street analysts, with an average price target reflecting confidence in its continued growth.

**5. Daiwa Securities Group Inc. Sells 6,055 Shares of Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251209T103119 | Neutral | Relevance: 99%
-  Daiwa Securities Group Inc. recently decreased its stake in Intuitive Surgical, Inc. by 6.0%, selling 6,055 shares, which reduced its holdings to 95,479 shares valued at $51.88 million. Other institutional investors have also adjusted their positions in ISRG, while analysts have issued a "Moderate Buy" consensus rating with a target price of $607.17. Additionally, company insiders, including EVP Brian Edward Miller and EVP Myriam Curet, have sold shares, bringing insider ownership to 0.70%.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($4.83M) |
| Sells | 10 ($1.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.6% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.8%)
- Blackrock Inc.: 8.8% (+0.1%)
- State Street Corpora: 4.3% (-0.1%)
- Price (T.Rowe) Assoc: 3.6% (-4.4%)
- Geode Capital Manage: 2.3% (+1.0%)

### Key Risks

1. Premium valuation (P/E 58x, PEG 2.8x) vulnerable to multiple compression.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.79 signals overvaluation risk, limited margin of safety. Forward P/E 58.3x stretched relative to 13% growth. Quality metrics strong (margin 29%). Balance sheet: strong liquidity (4.7x), low leverage (D/E 0.14). Insider buying signal ($4.8M), management confidence. Institutional flow bearish (4 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $203.2B |
| Beta | 1.69 |
| 52W Range | $425.00 - $616.00 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.79 |
| Forward P/E | 58.3 |
| Current P/E | 65.7 |
| YoY Growth | 12.7% |
| EPS Direction | RISING |

### Technicals

MRS_10 stable at -1.7% (minimal 5-day change). Below STRENGTH zone by 4.7pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.82), momentum weakening. RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.67% (CS: 38) | Neutral |
| RSI_14 | 57.7 | Neutral |
| MACD Histogram | -2.82 | Bearish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 1.093x | Above |
| vs SMA200 | 1.115x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $566.89
- **Stop Loss:** $541.83 (4.4% risk)
- **Target:** $591.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 19
- **Position Value:** $10,770.91
- **Portfolio %:** 10.77%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-22 (Est: $2.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.99 | $2.40 | +20.7% |
| 2025Q2 | $1.92 | $2.19 | +14.1% |
| 2025Q1 | $1.73 | $1.81 | +4.4% |
| 2024Q4 | $1.79 | $2.21 | +23.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*